Clinician-context page
This topic can involve test or imaging interpretation, neurological disease, surgery, medication, or complex underlying conditions. BioConst keeps this page as an explainer, not a decision guide.
What this means
Alzheimer disease is a progressive brain disorder that disrupts communication among neurons and gradually destroys memory, thinking, and daily function.[1,2,3]
What people may notice
- Memory problems are often early because Alzheimer disease first affects memory-related regions such as the entorhinal cortex and hippocampus.[1]
- As disease spreads, language, reasoning, social behavior, and independent function can become affected.[1,3]
- Later stages can involve broad brain-system failure and dependence on others for care.[1,3]
Key variables
Hippocampus / entorhinal memory network
Memory-related regions such as the entorhinal cortex and hippocampus are usually affected early.[1]
Beta-amyloid
Beta-amyloid can accumulate between neurons as plaques.[1]
Tau
Abnormal tau can form tangles inside neurons and disrupt transport and synaptic communication.[1]
Synaptic plasticity
Early loss of synaptic connections is a main hallmark of cognitive decline in Alzheimer disease.[1]
Why it happens
- NIA describes Alzheimer-related brain changes as a complex interplay among abnormal tau, beta-amyloid, and other factors.[1]
- Neurons lose connections, stop functioning properly, and eventually die, causing networks and brain regions to shrink.[1]
- Vascular issues can compound damage in some dementia contexts.[1,4]
Clinical response directions
- Modern diagnosis may use history, exam, cognitive tests, blood tests, genetic tests, brain scans, and other clinical tools depending on context.[3]
- Biomarkers and PET or blood-test advances can help detect Alzheimer-associated biology in living people, according to NIA.[1]
- BioConst frames this as mechanism explanation, not a diagnostic pathway for a reader.[3]